| Latest Advances in Cryogel Technology for Biomedical Applications A Memic, T Colombani, LJ Eggermont, M Rezaeeyazdi, J Steingold, ... Advanced Therapeutics, 1800114, 2019 | 253 | 2019 |
| Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells LJ Eggermont, LE Paulis, J Tel, CG Figdor Trends in biotechnology 32 (9), 456-465, 2014 | 241 | 2014 |
| Injectable Cryogels for Biomedical Applications LJ Eggermont, ZJ Rogers, T Colombani, A Memic, SA Bencherif Trends in biotechnology 38 (4), 418-431, 2019 | 163 | 2019 |
| Dendritic cells in cancer immunotherapy CM Le Gall, J Weiden, LJ Eggermont, CG Figdor Nature materials 17 (6), 474-475, 2018 | 101 | 2018 |
| Vascularization strategies for skin tissue engineering A Amirsadeghi, A Jafari, LJ Eggermont, SS Hashemi, SA Bencherif, ... Biomaterials Science 8 (15), 4073-4094, 2020 | 91 | 2020 |
| Injectable biomimetic hydrogels as tools for efficient T cell expansion and delivery J Weiden, D Voerman, Y Dölen, RK Das, A Van Duffelen, R Hammink, ... Frontiers in immunology 9, 2798, 2018 | 77 | 2018 |
| Controlling T-cell activation with synthetic dendritic cells using the multivalency effect R Hammink, S Mandal, LJ Eggermont, M Nooteboom, PHGM Willems, ... ACS omega 2 (3), 937-945, 2017 | 67 | 2017 |
| N-terminal dual protein functionalization by strain-promoted alkyne–nitrone cycloaddition RP Temming, L Eggermont, MB van Eldijk, JCM van Hest, FL van Delft Organic & Biomolecular Chemistry 11 (17), 2772-2779, 2013 | 57 | 2013 |
| Supramolecular self-assembled peptide-based vaccines: current state and future perspectives T Abdullah, K Bhatt, LJ Eggermont, N O'Hare, A Memic, SA Bencherif Frontiers in Chemistry 8, 598160, 2020 | 50 | 2020 |
| Cytokine‐functionalized synthetic dendritic cells for T cell targeted immunotherapies LJ Eggermont, R Hammink, KG Blank, AE Rowan, J Tel, CG Figdor Advanced Therapeutics 1 (6), 1800021, 2018 | 31 | 2018 |
| Oxygen‐generating cryogels restore T cell mediated cytotoxicity in hypoxic tumors T Colombani, LJ Eggermont, SM Hatfield, ZJ Rogers, M Rezaeeyazdi, ... Advanced functional materials 31 (37), 2102234, 2021 | 30 | 2021 |
| Antimicrobial hydrogels: Key considerations and engineering strategies for biomedical applications K Joshi Navare, LJ Eggermont, ZJ Rogers, HS Mohammed, T Colombani, ... Racing for the Surface: Pathogenesis of Implant Infection and Advanced …, 2020 | 23 | 2020 |
| Biomaterials and oxygen join forces to shape the immune response and boost COVID‐19 vaccines T Colombani, LJ Eggermont, ZJ Rogers, LGA McKay, LE Avena, ... Advanced Science 8 (18), 2100316, 2021 | 20 | 2021 |
| Engineering hyaluronic acid-based cryogels for CD44-mediated breast tumor reconstruction M Rezaeeyazdi, T Colombani, LJ Eggermont, SA Bencherif Materials Today Bio 13, 100207, 2022 | 19 | 2022 |
| Semiflexible immunobrushes induce enhanced T cell activation and expansion R Hammink, J Weiden, D Voerman, C Popelier, LJ Eggermont, M Schluck, ... ACS applied materials & interfaces 13 (14), 16007-16018, 2021 | 18 | 2021 |
| Engineering a macroporous fibrin-based sequential interpenetrating polymer network for dermal tissue engineering O Gsib, LJ Eggermont, C Egles, SA Bencherif Biomaterials Science 8 (24), 7106-7116, 2020 | 17 | 2020 |
| Affinity-based purification of polyisocyanopeptide bioconjugates R Hammink, LJ Eggermont, T Zisis, J Tel, CG Figdor, AE Rowan, ... Bioconjugate Chemistry 28 (10), 2560-2568, 2017 | 15 | 2017 |
| Harnessing biomaterials for therapeutic strategies against COVID-19 T Colombani, ZJ Rogers, LJ Eggermont, SA Bencherif Emergent materials 4, 9-18, 2021 | 12 | 2021 |
| Synthetic semiflexible and bioactive brushes D Voerman, M Schluck, J Weiden, B Joosten, LJ Eggermont, ... Biomacromolecules 20 (7), 2587-2597, 2019 | 12 | 2019 |
| Direct in vivo activation of T cells with nanosized immunofilaments inhibits tumor growth and metastasis L Weiss, J Weiden, Y Dölen, EM Grad, EAW van Dinther, M Schluck, ... Acs Nano 17 (13), 12101-12117, 2023 | 10 | 2023 |
Carl G. Figdorprof在 radboudumc.nl 的电子邮件经过验证
